Dr. McCormick’s fundamental research decoding the behavior and structure of KRAS turns one of cancer’s toughest genes into a target for therapy.
Category:Cover Story
Dr. Mardis is a trailblazer in developing next-generation sequencing technologies.
Dr. Winn recognized that improving care for all cancer patients means bringing translational research into at-risk rural and urban communities.
Dr. Dang was among the first to discover that MYC oncogenes regulate tumor metabolism.
The CAR T-cell pioneer developed breakthrough therapies for blood cancer patients. Now he has turned his attention to solid-tumor cancers.